Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_assertion type Assertion NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_head.
- NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_assertion description "[The setup of anti-HER2 targeting strategies has revolutionized the clinical outcome of HER2(+) breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_provenance.
- NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_assertion evidence source_evidence_literature NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_provenance.
- NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_assertion SIO_000772 25136593 NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_provenance.
- NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_assertion wasDerivedFrom befree-2016 NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_provenance.
- NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_assertion wasGeneratedBy ECO_0000203 NP1211874.RAXC5Nlr52Up1DjBp3jmOgmgNv3jkXxboNj0qfdnSwl9s130_provenance.